Application of Nanodrug Delivery Systems in Enhancing Treatment of Gastritis and Gastric Cancer: A Systematic Evaluation of Targeted Therapy
In recent years, nanomedicine has been emerging as a promising therapeutic approach in the treatment of gastritis and gastric cancer, particularly through targeted drug delivery systems and combination therapies that enhance therapeutic effects. Gastritis and gastric cancer, being common gastrointes...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/6/683 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839653063208468480 |
|---|---|
| author | Miaomiao Xu Shujie Tian Jing Wang Shuqing Gan Ziting Zhang Lixing Weng |
| author_facet | Miaomiao Xu Shujie Tian Jing Wang Shuqing Gan Ziting Zhang Lixing Weng |
| author_sort | Miaomiao Xu |
| collection | DOAJ |
| description | In recent years, nanomedicine has been emerging as a promising therapeutic approach in the treatment of gastritis and gastric cancer, particularly through targeted drug delivery systems and combination therapies that enhance therapeutic effects. Gastritis and gastric cancer, being common gastrointestinal diseases, often exhibit suboptimal treatment outcomes due to the limitations of traditional medications. Interventions based on nanotechnology not only improve the local concentration and bioavailability of drugs but also promote precise targeted therapy by regulating drug release rates, while minimizing adverse side effects, thereby enhancing therapeutic efficacy. Despite significant progress in basic research and preclinical applications, the clinical translation of nanomedicine still faces numerous challenges, including stability, biocompatibility, production standardization, regulatory and ethical barriers, as well as optimization of clinical trial designs. Furthermore, combining nanomedicine with other therapeutic modalities, such as immunotherapy and gene therapy, may open new avenues for addressing complex digestive system diseases. Future research should continue to explore the potential of nanocarriers, particularly in the formulation and stability of nanomaterials for precision therapy, with the aim of improving the quality of life and survival rates for patients with gastritis and gastric cancer. |
| format | Article |
| id | doaj-art-ea3b37b4833a4f1790a9cb9dd0ec2a4c |
| institution | Matheson Library |
| issn | 1999-4923 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceutics |
| spelling | doaj-art-ea3b37b4833a4f1790a9cb9dd0ec2a4c2025-06-25T14:18:00ZengMDPI AGPharmaceutics1999-49232025-05-0117668310.3390/pharmaceutics17060683Application of Nanodrug Delivery Systems in Enhancing Treatment of Gastritis and Gastric Cancer: A Systematic Evaluation of Targeted TherapyMiaomiao Xu0Shujie Tian1Jing Wang2Shuqing Gan3Ziting Zhang4Lixing Weng5State Key Laboratory of Flexible Electronics (LoFE), Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, Nanjing 210049, ChinaState Key Laboratory of Flexible Electronics (LoFE), Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, Nanjing 210049, ChinaState Key Laboratory of Flexible Electronics (LoFE), Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, Nanjing 210049, ChinaState Key Laboratory of Flexible Electronics (LoFE), Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, Nanjing 210049, ChinaState Key Laboratory of Flexible Electronics (LoFE), Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, Nanjing 210049, ChinaState Key Laboratory of Flexible Electronics (LoFE), Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, Nanjing 210049, ChinaIn recent years, nanomedicine has been emerging as a promising therapeutic approach in the treatment of gastritis and gastric cancer, particularly through targeted drug delivery systems and combination therapies that enhance therapeutic effects. Gastritis and gastric cancer, being common gastrointestinal diseases, often exhibit suboptimal treatment outcomes due to the limitations of traditional medications. Interventions based on nanotechnology not only improve the local concentration and bioavailability of drugs but also promote precise targeted therapy by regulating drug release rates, while minimizing adverse side effects, thereby enhancing therapeutic efficacy. Despite significant progress in basic research and preclinical applications, the clinical translation of nanomedicine still faces numerous challenges, including stability, biocompatibility, production standardization, regulatory and ethical barriers, as well as optimization of clinical trial designs. Furthermore, combining nanomedicine with other therapeutic modalities, such as immunotherapy and gene therapy, may open new avenues for addressing complex digestive system diseases. Future research should continue to explore the potential of nanocarriers, particularly in the formulation and stability of nanomaterials for precision therapy, with the aim of improving the quality of life and survival rates for patients with gastritis and gastric cancer.https://www.mdpi.com/1999-4923/17/6/683nanomedicinegastritisgastric cancerclinical translationstabilityprecision therapy |
| spellingShingle | Miaomiao Xu Shujie Tian Jing Wang Shuqing Gan Ziting Zhang Lixing Weng Application of Nanodrug Delivery Systems in Enhancing Treatment of Gastritis and Gastric Cancer: A Systematic Evaluation of Targeted Therapy Pharmaceutics nanomedicine gastritis gastric cancer clinical translation stability precision therapy |
| title | Application of Nanodrug Delivery Systems in Enhancing Treatment of Gastritis and Gastric Cancer: A Systematic Evaluation of Targeted Therapy |
| title_full | Application of Nanodrug Delivery Systems in Enhancing Treatment of Gastritis and Gastric Cancer: A Systematic Evaluation of Targeted Therapy |
| title_fullStr | Application of Nanodrug Delivery Systems in Enhancing Treatment of Gastritis and Gastric Cancer: A Systematic Evaluation of Targeted Therapy |
| title_full_unstemmed | Application of Nanodrug Delivery Systems in Enhancing Treatment of Gastritis and Gastric Cancer: A Systematic Evaluation of Targeted Therapy |
| title_short | Application of Nanodrug Delivery Systems in Enhancing Treatment of Gastritis and Gastric Cancer: A Systematic Evaluation of Targeted Therapy |
| title_sort | application of nanodrug delivery systems in enhancing treatment of gastritis and gastric cancer a systematic evaluation of targeted therapy |
| topic | nanomedicine gastritis gastric cancer clinical translation stability precision therapy |
| url | https://www.mdpi.com/1999-4923/17/6/683 |
| work_keys_str_mv | AT miaomiaoxu applicationofnanodrugdeliverysystemsinenhancingtreatmentofgastritisandgastriccancerasystematicevaluationoftargetedtherapy AT shujietian applicationofnanodrugdeliverysystemsinenhancingtreatmentofgastritisandgastriccancerasystematicevaluationoftargetedtherapy AT jingwang applicationofnanodrugdeliverysystemsinenhancingtreatmentofgastritisandgastriccancerasystematicevaluationoftargetedtherapy AT shuqinggan applicationofnanodrugdeliverysystemsinenhancingtreatmentofgastritisandgastriccancerasystematicevaluationoftargetedtherapy AT zitingzhang applicationofnanodrugdeliverysystemsinenhancingtreatmentofgastritisandgastriccancerasystematicevaluationoftargetedtherapy AT lixingweng applicationofnanodrugdeliverysystemsinenhancingtreatmentofgastritisandgastriccancerasystematicevaluationoftargetedtherapy |